Morpho Midnight introduces fixed-rate onchain lending with capped fees, pooled liquidity, and precise liquidation rules for ...

Leading organizations are no longer waiting for quantum computing to mature, instead they're building knowledge, assessing ...

Learn about sinkable bonds, secured by sinking funds, providing low-risk investment benefits, and delve into how they work ...

Fed expected to hold interest rates flat amid rising inflation under new chair Kevin Warsh. Here's what investors should ...

Think you understand the middle class? These four insights on income, taxes, homeownership and wealth may change how you see ...

Multi-organ system and quality-of-life benefits sustained through three and a half years 86% response rate for the multi-component endpoint 89% ...

Over three decades of working with CEOs, boards, and leadership teams across venture-backed startups, PE portfolio companies, ...

Electromed benefits from a new CMS rule and a recently approved bronchiectasis drug, driving increased disease awareness.

We’re still in the very early days of AI. Like in a game of poker, most CEOs are cautiously placing their ...

Mitapivat demonstrated statistically significant improvement in hemoglobin response compared with placebo, with rapid onset and durable ...

For Europe to remain an attractive site for phase 3 research, he argued, regulatory predictability is paramount. El-Galaly ...